The Enterprise Value as of December 2025 (TTM) for Eris Lifesciences Limited (ERIS.NS) is 234.70B

According to Eris Lifesciences Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 234.70B. This represents a change of 8.21% compared to the average of 216.88B of the last 4 quarters.

Eris Lifesciences Limited (ERIS.NS) Historical Enterprise Value (quarterly & annually)

How has ERIS.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Eris Lifesciences Limited over the last ten years is 103.47B. The current 234.70B Enterprise Value has changed 22.58% with respect to the historical average. Over the past ten years (40 quarters), ERIS.NS's Enterprise Value was at its highest in in the September 2025 quarter at 239.44B. The Enterprise Value was at its lowest in in the January 2016 quarter at 0.

Eris Lifesciences Limited (ERIS.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Eris Lifesciences Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eris Lifesciences Limited (ERIS.NS) Average Enterprise Value

How has ERIS.NS Enterprise Value performed in the past?

The current Enterprise Value of Eris Lifesciences Limited (ERIS.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eris Lifesciences Limited (ERIS.NS) Enterprise Value vs. Peers

How is ERIS.NS’s Enterprise Value compared to its peers?

Eris Lifesciences Limited’s Enterprise Value is greater than Neuland Laboratories Limited (218.89B), greater than Neuland Laboratories Limited (218.89B), greater than Alembic Pharmaceuticals Limited (190.32B), greater than Jubilant Pharmova Limited (192.78B), greater than Jubilant Pharmova Limited (192.78B), greater than Alembic Pharmaceuticals Limited (190.32B), less than Piramal Enterprises Limited (254.86B), less than Wockhardt Limited (243.21B), less than Wockhardt Limited (243.21B), greater than AstraZeneca Pharma India Limited (227.02B),

Build a custom stock screener for Eris Lifesciences Limited (ERIS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eris Lifesciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eris Lifesciences Limited (ERIS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eris Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.